Skip to main content Accessibility help
×
Home

Paliperidone palmitate versus other antipsychotics

  • P. Hervías Higueras (a1), L. Maroto Martín (a1), S. Raffo Moncloa (a1) and M. Leonor del Pozo (a2)

Abstract

The aim of the study was to describe the psychopharmacological treatments received by inpatients diagnosed with spectrum disorders schizophrenia and other psychotic disorders in Dr. Rodriguez Lafora Hospital. It is an observational, descriptive and retrospective study. We collected information about patients aged 18 to 64 who were hospitalized during the month of January of 2015 in the acute psychiatric hospitalization by Selene software. We reviewed treatments and number of psychiatric re-hospitalization six months later and we analyzed the results by SPSS software. From a sample of 51 inpatients, 15 of them were diagnosed with disorders of the spectrum of schizophrenia and other psychotic disorders. Of the patients, 13.3% was treated with haloperidol, 26.7% with olanzapine, 26.7% with risperidone although it was modified by paliperidone in mental health center, 6.7% with quetiapine, 6.7% with amisulpride, 13.3% with oral paliperidone and 13.3% patients with intramuscular paliperidone. Of these, 40% are readmitted to hospital. Patients were readmitted due to ineffectiveness and adverse effects of haloperidol, olanzapine, risperidone. 73.3% of inpatients were treated with monotherapy. Of the patients, 26.7% were treated with polytherapy, who received olanzapine, risperidone and amisulpride. It would be important to use psychoactive substances that allow monotherapy to reduce adverse effects and psychiatric re-hospitalization.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Copyright

Corresponding author

*Corresponding author.

Paliperidone palmitate versus other antipsychotics

  • P. Hervías Higueras (a1), L. Maroto Martín (a1), S. Raffo Moncloa (a1) and M. Leonor del Pozo (a2)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

Paliperidone palmitate versus other antipsychotics

  • P. Hervías Higueras (a1), L. Maroto Martín (a1), S. Raffo Moncloa (a1) and M. Leonor del Pozo (a2)
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *